Lv2
134 积分 2024-11-09 加入
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
1个月前
已完结
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
1个月前
已完结
Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes
1个月前
已完结
Effect of the glucagon‐like peptide‐1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
1个月前
已完结
Beyond glycaemic control: A cross‐over, double‐blinded, 24‐week intervention with liraglutide in type 1 diabetes
1个月前
已完结
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Turning the Tide of Obesity Medicine: Tirzepatide in the Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans with Overweight/Obesity
1个月前
已完结
Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non‐Diabetic Adults: A Meta‐Analysis of Randomised Controlled Trials
1个月前
已完结
Tirzepatide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits
1个月前
已关闭
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
1个月前
已完结
皖公网安备34019202002308
